Discover the challenges of treating resistant vaginal thrush and the rise of non-albicans Candida species. Learn about new ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid significant yearly increases in the prevalence of fungal infections caused by fungal Candida species, ...

However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button. Candida auris is an emerging multidrug-resistant pathogenic yeast capable of causing severe ...

When there is too much yeast, you can have vaginal burning and/or itching and sometimes a sticky, white vaginal discharge. This is called a vulvovaginal candidiasis (VVC) infection or "yeast ...

Between 2020 and 2021, the U.S. saw a 95 percent rise in these treatment-resistant infections, roughly a third of which were fatal.

Antimicrobial-resistant infections can worsen existing mental health issues or create new ones. Isolation and lifestyle ...

Candidiasis, likely affectionately known to you as thrush, is an infection caused by an overgrowth of a yeast called candida. It can show up in many in parts of the body, including the mouth ...

Oral thrush is a yeast infection occurring in the mouth and throat as a result of an excess of Candida albicans, a typical yeast found in the oral cavity. This condition can lead to the formation ...

Maxim representative. SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections ...

About fosmanogepix Fosmanogepix is a clinical-stage broad-spectrum antifungal. It has a novel mechanism of action and its ...